Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

Analyst Jack Allen from Robert W. Baird maintained a Buy rating on Mereo Biopharma Group Plc (MREO – Research Report) and keeping the ...

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Hold rating on Fulcrum Therapeutics (FULC – Research Report). The associated ...

The launch of emerging therapies, such as LNZ100 by Lenz Therapeutics, Phentolamine Ophthalmic Solution 0.75% by Viatris an ...

Women have been speaking about pre-menstrual syndrome from decades, but could men be experiencing the same cycle? We asked ...

His extensive experience in the MedTech industry and proven leadership in guiding companies through significant growth phases make him an invaluable ... The Maryland Stem Cell Research Commission ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...

Doctors at Zuckerberg San Francisco General Hospital are using a cutting-edge AI tool to analyze medical scans, helping them ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...